Testing a closed-loop insulin system for kids with type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This trial studies how the Medtronic 780G “closed-loop” insulin system works for young people with type 1 diabetes. It may help by improving how automatically insulin is delivered, depending on your body’s needs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have type 1 diabetes
- You must have had type 1 diabetes for at least 6 months
- You need to attend regular clinic visits for this study
- You must be starting or have started using the Medtronic 780G system
- You must be at least 1 year old
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new insulin pump system (Tandem Mobi) with a continuous glucose monitor for young athletes with type 1 diabetes. It looks at how well the system works and how it feels to use during sports.
This study tests a semi-automated insulin pump system in very young children (ages 2–6) with type 1 diabetes. It aims to see if the device improves quality of life and blood sugar control.
This study tests a new hybrid closed-loop system (an automated insulin pump) in people with type 1 diabetes whose blood sugar is not well controlled. It aims to see if the system is safe and helps improve glucose levels.
This study tests a new automated insulin delivery system to help people with type 1 diabetes better manage their blood sugar. It aims to see if the system improves glucose control safely.
This trial compares taking your rapid insulin at mealtime versus after a meal when using the Medtronic 780G pump. It aims to see which timing helps better manage blood sugar.
This study tests a new insulin pump system (MiniMed 780G) in children aged 7-17 who were recently diagnosed with type 1 diabetes. It aims to see if this pump helps control blood sugar better and improves quality of life compared to standard insulin shots or older pumps.
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.